Top Buy
Security | Buy ▲ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Vanda Pharmaceuticals | 4 | 0 | 2 | 0 | €4.54 | €5.00 | 10.132% |
Kala Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €5.97 | €19.86 | 233.024% |
Actinium Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €6.77 | €8.50 | 25.554% |
Canopy Growth Corp | 4 | 0 | 0 | 0 | €0.47 | €1.75 | 273.134% |
AC Immune Ltd | 4 | 0 | 0 | 0 | €2.26 | €12.27 | 444.284% |
Community Health Systems Inc. | 4 | 3 | 1 | 0 | €3.08 | €5.36 | 74.169% |
Anika Therapeutics | 4 | 0 | 0 | 0 | €24.40 | €26.58 | 8.940% |
Twist Bioscience Corp | 4 | 0 | 1 | 0 | €29.80 | €40.70 | 36.592% |
Sanofi S.A. | 4 | 0 | 1 | 0 | €93.05 | €99.50 | 6.932% |
Xeris Biopharma Holdings Inc. | 4 | 0 | 0 | 0 | €1.64 | €4.39 | 168.253% |
Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |
Galmed Pharmaceuticals Ltd. | 4 | 0 | 0 | 0 | €0.36 | €61.56 | 16999.750% |
Healthstream Inc. | 4 | 0 | 0 | 0 | €23.40 | €29.29 | 25.183% |
Chemed Corp. | 4 | 0 | 0 | 0 | €515.00 | €588.14 | 14.202% |
Apellis Pharmaceuticals | 4 | 0 | 0 | 0 | €39.75 | €70.00 | 76.101% |
Quest Diagnostics Inc. | 4 | 0 | 1 | 0 | €130.20 | €144.44 | 10.940% |
Hutchison China MediTech Ltd ADR | 5 | 0 | 0 | 0 | €17.30 | €45.10 | 160.665% |
Agios Pharmaceuticals Inc. | 5 | 0 | 2 | 0 | €30.60 | €38.99 | 27.414% |
Glycomimetics Inc. | 5 | 0 | 0 | 0 | €1.45 | €7.35 | 407.007% |
Atossa Genetics Inc | 5 | 1 | 2 | 0 | €1.45 | €3.72 | 155.736% |
SCYNEXIS Inc. | 5 | 0 | 2 | 0 | €1.73 | €3.00 | 73.611% |
Adverum Biotechnologies Inc. | 5 | 1 | 1 | 0 | €1.38 | €4.66 | 237.768% |
Dr. Reddy's Laboratories Ltd. ADR | 5 | 1 | 1 | 0 | €69.00 | €73.92 | 7.130% |
Personalis Inc | 5 | 0 | 1 | 0 | €1.30 | €3.23 | 148.178% |
XOMA Corp. | 5 | 0 | 2 | 0 | €23.20 | €68.62 | 195.777% |